Ariel Investments, an investment management company, released its “Ariel Appreciation Fund” second-quarter 2025 investor ...

Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the best biotech stocks to buy according to billionaire Steve Cohen. On July 10, Goldman Sachs resumed coverage of the stock with a ‘Buy’ rating and a $19 ...

Rahul Jain, Head of India Equity Research & Asia Financials at Goldman Sachs, told NDTV Profit that FY27 will be 'very strong ...

In a June 24, 2025, podcast, Goldman Sachs’ Christian Mueller-Glissmann and Alexandra Wilson-Elizondo examined the dynamics driving markets.

BlackBerry Limited (NYSE:BB) is one of Goldman Sachs’ top penny stock picks. On June 15, Raymond James kept a “Market Perform” rating on BlackBerry after better-than-expected quarterly results.

Goldman Sachs analyst initiates coverage of Nebius Group with a Buy rating, citing its strong position in the AI Neoclouds ...

Investing.com -- Goldman Sachs has initiated coverage on Nebius Group (NASDAQ: NBIS) with a “buy” rating, pointing to the company’s position as a leading provider of AI infrastructure and forecasting ...

The AI room really has some strong legs as we march through the peak of the summer season. And while investors should always ...

Goldman Sachs downgraded the stock to Neutral from Buy, with a target price of 310,000 won. The investment bank said that ...

Goldman Sachs says Nvidia, Broadcom, Cadence and Synopsys are best positioned for the next phase of AI growth. AMD, Arm, and Marvell fall short.

The AI boom has been generating hype and headlines for several years now, and deservedly so. It’s transforming the way ...

Some analysts remain optimistic about continued market strength. Scott Rubner from Citadel Securities indicated retail traders could provide support for the rally. Tully suggested that if the Fed ...